MIR3913-2: A Drug Target / Disease Biomarker (G100500868)

MIR3913-2: A Drug Target / Disease Biomarker

MIR3913-2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various cellular processes. One of the unique aspects of MIR3913-2 is its structure. It is a monocystic protein, which means that it consists of a single polypeptide chain that is encoded by a single gene.

MIR3913-2 has been shown to play a role in a variety of physiological processes in the body. For example, it is involved in the regulation of ion and water transport in the brain, which is important for maintaining the proper functioning of the brain cells. It is also involved in the regulation of the blood pressure, which is important for maintaining the cardiovascular system.

In addition to its role in regulation, MIR3913-2 has also been shown to be a potential drug target. Researchers have identified several potential drug targets for MIR3913-2, including those that are involved in the regulation of ion and water transport, blood pressure, and inflammation.

One of the potential drug targets for MIR3913-2 is the Wnt signaling pathway, which is a well-established pathway for the regulation of cell growth and differentiation. The Wnt signaling pathway is involved in the development and maintenance of various tissues in the body, including the brain and heart.

Research has shown that MIR3913-2 is involved in the regulation of ion and water transport in the brain, which is important for the development and maintenance of the brain cells. This suggests that MIR3913-2 may be a useful drug target for the treatment of a variety of neurological disorders, including those that are characterized by ion and water transport disorders.

Another potential drug target for MIR3913-2 is the TGF-β signaling pathway, which is involved in the regulation of cell growth and differentiation. The TGF-β signaling pathway is a well-established pathway for the regulation of various tissues in the body, including the brain and heart.

Research has shown that MIR3913-2 is involved in the regulation of blood pressure, which is important for maintaining the cardiovascular system. This suggests that MIR3913-2 may be a useful drug target for the treatment of hypertension, which is a common cardiovascular disorder that can lead to a variety of serious health complications, including heart attack, stroke, and heart failure.

In addition to its potential drug targets, MIR3913-2 has also been shown to be involved in the regulation of inflammation. This suggests that MIR3913-2 may be a useful drug target for the treatment of a variety of inflammatory disorders, including those that affect the brain and other tissues.

Overall, MIR3913-2 is a protein that has been shown to play a variety of important roles in various physiological processes in the body. Its unique structure, as well as its involvement in the regulation of ion and water transport, blood pressure, and inflammation, make it a promising candidate for a variety of drug targets. Further research is needed to fully understand the role of MIR3913-2 in the body and to develop effective treatments for the various disorders that it is involved in.

Protein Name: MicroRNA 3913-2

The "MIR3913-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3913-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299